James Welch

522 total citations
23 papers, 302 citations indexed

About

James Welch is a scholar working on Epidemiology, Nephrology and Neurology. According to data from OpenAlex, James Welch has authored 23 papers receiving a total of 302 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 10 papers in Nephrology and 7 papers in Neurology. Recurrent topics in James Welch's work include Neuroendocrine Tumor Research Advances (14 papers), Parathyroid Disorders and Treatments (10 papers) and Neuroblastoma Research and Treatments (7 papers). James Welch is often cited by papers focused on Neuroendocrine Tumor Research Advances (14 papers), Parathyroid Disorders and Treatments (10 papers) and Neuroblastoma Research and Treatments (7 papers). James Welch collaborates with scholars based in United States, Israel and France. James Welch's co-authors include William F. Simonds, Sunita Agarwal, Electron Kebebew, Bin Guan, Stephen J. Marx, Hua Ling, Lee S. Weinstein, Yu‐Long Li, Jennifer J. Johnston and Julie C. Sapp and has published in prestigious journals such as New England Journal of Medicine, The Journal of Clinical Endocrinology & Metabolism and The Lancet Oncology.

In The Last Decade

James Welch

21 papers receiving 299 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James Welch United States 9 187 147 108 102 64 23 302
Pamela Correa Sweden 8 211 1.1× 85 0.6× 139 1.3× 113 1.1× 91 1.4× 8 408
Jacek Gawrychowski Poland 10 112 0.6× 51 0.3× 51 0.5× 91 0.9× 59 0.9× 45 323
Elizaveta Mamedova Russia 9 117 0.6× 40 0.3× 42 0.4× 86 0.8× 35 0.5× 37 193
Jordan L. Geller United States 7 102 0.5× 54 0.4× 81 0.8× 74 0.7× 43 0.7× 12 293
Anna Eremkina Russia 8 159 0.9× 26 0.2× 58 0.5× 59 0.6× 32 0.5× 88 251
Karin van der Tuin Netherlands 6 47 0.3× 34 0.2× 41 0.4× 37 0.4× 31 0.5× 9 199
D B Calandra United States 8 112 0.6× 58 0.4× 54 0.5× 84 0.8× 27 0.4× 10 344
Lars Wikström Sweden 11 63 0.3× 124 0.8× 41 0.4× 74 0.7× 430 6.7× 13 482
Crystal Kamilaris United States 7 22 0.1× 103 0.7× 30 0.3× 80 0.8× 47 0.7× 14 323
Franco Bergesio Italy 10 128 0.7× 49 0.3× 28 0.3× 53 0.5× 268 4.2× 11 322

Countries citing papers authored by James Welch

Since Specialization
Citations

This map shows the geographic impact of James Welch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Welch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Welch more than expected).

Fields of papers citing papers by James Welch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Welch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Welch. The network helps show where James Welch may publish in the future.

Co-authorship network of co-authors of James Welch

This figure shows the co-authorship network connecting the top 25 collaborators of James Welch. A scholar is included among the top collaborators of James Welch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Welch. James Welch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Welch, James, Lynn S. Bliss, Craig Cochran, et al.. (2025). Genotype-phenotype correlation in multiple endocrine neoplasia type 1. JCI Insight. 10(6).
2.
Guan, Bin, Sunita Agarwal, James Welch, et al.. (2024). A Germline ZFX Missense Variant in a Patient With Primary Hyperparathyroidism. JCEM Case Reports. 2(8). luae115–luae115.
3.
Welch, James, Jian Sun, Sunita Agarwal, et al.. (2023). Phenotypic Profiling and Molecular Mechanisms in Hyperparathyroidism-jaw Tumor Syndrome. The Journal of Clinical Endocrinology & Metabolism. 108(12). 3165–3177. 13 indexed citations
4.
Jha, Smita, James Welch, Justin Lack, et al.. (2023). Germline- and Somatic-Inactivating FLCN Variants in Parathyroid Cancer and Atypical Parathyroid Tumors. The Journal of Clinical Endocrinology & Metabolism. 108(10). 2686–2698. 7 indexed citations
5.
Welch, James, Rashika Bansal, Vaishali I. Parekh, et al.. (2022). Metastatic Grade 3 Neuroendocrine Tumor in Multiple Endocrine Neoplasia Type 1 Expressing Somatostatin Receptors. Journal of the Endocrine Society. 6(10). bvac122–bvac122. 2 indexed citations
6.
Welch, James, Sriram Gubbi, Sudheer Kumar Gara, et al.. (2021). Co-Occurrence of Familial Non-Medullary Thyroid Cancer (FNMTC) and Hereditary Non-Polyposis Colorectal Cancer (HNPCC) Associated Tumors—A Cohort Study. Frontiers in Endocrinology. 12. 653401–653401. 4 indexed citations
7.
Welch, James, Sunita Agarwal, Craig Cochran, et al.. (2021). Thymoma and Not Just Thymic Carcinoid Can Be Associated With Multiple Endocrine Neoplasia Type 1. Journal of the Endocrine Society. 5(Supplement_1). A1007–A1008. 1 indexed citations
8.
Burbelo, Peter D., Giovanni Di Pasquale, James Welch, et al.. (2021). Parathyroid Hormone Resistance and Autoantibodies to the PTH1 Receptor. New England Journal of Medicine. 385(21). 1974–1980. 4 indexed citations
9.
Gubbi, Sriram, Shilpa Thakur, Armando Filie, et al.. (2020). Comprehensive guidance on the diagnosis and management of primary mesenchymal tumours of the thyroid gland. The Lancet Oncology. 21(11). e528–e537. 8 indexed citations
10.
Agarwal, Sunita, James Welch, Rashika Bansal, et al.. (2020). Patients With MEN1 Are at an Increased Risk for Venous Thromboembolism. The Journal of Clinical Endocrinology & Metabolism. 106(2). e460–e468. 5 indexed citations
11.
Li, Yulong, Jianhua Zhang, James Welch, et al.. (2020). Genotype of CDC73 germline mutation determines risk of parathyroid cancer. Endocrine Related Cancer. 27(9). 483–494. 29 indexed citations
12.
Welch, James, Sunita Agarwal, Naris Nilubol, et al.. (2020). 18F-FDOPA PET/CT accurately identifies MEN1-associated pheochromocytoma. Endocrinology Diabetes and Metabolism Case Reports. 2020. 10 indexed citations
13.
14.
Suzuki, Mari, James Welch, Sunita Agarwal, et al.. (2019). Clinical presentation and management of primary ovarian neuroendocrine tumor in multiple endocrine neoplasia type 1. Endocrinology Diabetes and Metabolism Case Reports. 2019. 10 indexed citations
15.
Lakis, Mustapha El, Pavel Nockel, Apostolos Gaitanidis, et al.. (2018). Probability of Positive Genetic Testing Results in Patients with Family History of Primary Hyperparathyroidism. Journal of the American College of Surgeons. 226(5). 933–938. 22 indexed citations
16.
Rahmani, Maziar, et al.. (2018). First report of concomitant pheochromocytoma and duodenal neuroendocrine tumour in a sporadic multiple endocrine neoplasia type 1. BMJ Case Reports. 2018. bcr–2017. 1 indexed citations
17.
Lakis, Mustapha El, Pavel Nockel, Bin Guan, et al.. (2017). Familial isolated primary hyperparathyroidism associated with germline GCM2 mutations is more aggressive and has a lesser rate of biochemical cure. Surgery. 163(1). 31–34. 26 indexed citations
18.
Guan, Bin, James Welch, Meghana Vemulapalli, et al.. (2017). Ethnicity of Patients With Germline GCM2-Activating Variants and Primary Hyperparathyroidism. Journal of the Endocrine Society. 1(5). 488–499. 29 indexed citations
19.
Guan, Bin, James Welch, Julie C. Sapp, et al.. (2016). GCM2 -Activating Mutations in Familial Isolated Hyperparathyroidism. The American Journal of Human Genetics. 99(5). 1034–1044. 97 indexed citations
20.
Keutgen, Xavier M., Naris Nilubol, Sunita Agarwal, et al.. (2016). Reoperative Surgery in Patients with Multiple Endocrine Neoplasia Type 1 Associated Primary Hyperparathyroidism. Annals of Surgical Oncology. 23(S5). 701–707. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pamela Correa Breakdown of academic impact, for papers by Jacek Gawrychowski Breakdown of academic impact, for papers by Elizaveta Mamedova Breakdown of academic impact, for papers by Jordan L. Geller Breakdown of academic impact, for papers by Anna Eremkina Breakdown of academic impact, for papers by Karin van der Tuin Breakdown of academic impact, for papers by D B Calandra Breakdown of academic impact, for papers by Lars Wikström Breakdown of academic impact, for papers by Crystal Kamilaris Breakdown of academic impact, for papers by Franco Bergesio
Rankless by CCL
2026